Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: INJECTION DICLOFENAC 75 MG: GROUP B INJECTION DICLOFENAC 75 mg 30 minutes before extubation stat dose by intramuscular route.Total duration for intervention is for one year
Control Inte
Sponsors
Rohilkhand medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: American society of Anaesthesiologist (ASA) grade I or II. Age group Between 18-60 yrs of either sex
Exclusion criteria
Exclusion criteria: Pregnant females. Patients with co-morbid diseases like diabetes, hypertension, TB, HIV, neurological,psychiatric or neuro-vascular disorders. Patients with history of asthma,urticaria and hypersensitivity to any component of diclofenac patch or injection. Patients with gastrointestinal tract related problems(gastritis, ulcers, bleeding & perforation). Patients with skin diseases (eczema, fungal infection, inflammation, burn wound). Patients with history of alcohol abuse, blood (porphyria, bleeding or clotting disorders) and vascular disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the analgesic effect between transdermal patch of diclofenac and intramuscular diclofenac. To document adverse effects. To assess requirement of rescue analgesia. To compare VAS and QoR-15 score for one year Timepoint: To compare the analgesic effect between transdermal patch of diclofenac and intramuscular diclofenac at 2,4,6,8,10,12,24 hours. To document adverse effects at 2,4,6,8,10,12,24 hours. To assess requirement of rescue analgesia at 2,4,6,8,10,12,24 hours. To compare VAS score at 2,4,6,8,10,12,24 hours and QoR-15 score after 24 hours. Total Duration for one year | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sarfaraz Ahmad
Rohilkhand medical college and hospital
Outcome results
None listed